Announcing Our New Exclusive Partnership with PharmiGENE in Taiwan
Bioelectronica Holdings Inc. is proud to announce a new exclusive distribution partnership with PharmiGENE, a leading life sciences company based in Taiwan. Under this partnership, PharmiGENE will serve as our exclusive distributor in Taiwan, helping expand access to our cutting-edge technologies across the region.
PharmiGENE has a strong track record of delivering high-quality genomics and molecular biology solutions to local customers. Among its impressive portfolio is 10x Genomics, a key component of our own workflow. This strategic alignment makes PharmiGENE an ideal partner to support our continued growth and customer success in Taiwan.
With this collaboration, customers in Taiwan will benefit from a seamless, end-to-end solution—from sample prep to analysis—making Bioelectronica’s products more accessible through a one-stop-shop experience.
“
We’re excited to partner with PharmiGENE and expand our presence in Taiwan. Their deep expertise and existing portfolio, including 10x Genomics, align perfectly with our technology and mission. Together, we’ll deliver more value to customers by offering a comprehensive and integrated solution.
”
Allen Zhang, COO of Bioelectronica
We look forward to growing together with PharmiGENE and delivering impactful innovation to the scientific community in Taiwan.
Welcome aboard, PharmiGENE!
For distribution or product inquiries in Taiwan, please contact PharmiGENE directly or reach out to our global support team.
About PhariGENE
PharmiGENE was established in 2005 and funded by venture capitalists and angel investors. Our goal is to innovate and commercialize diagnostic tests that enable everyone to be better informed about his/her genetic makeup and to make decisions that can better their health. We have licensed from Academia Sinica the exclusive rights to key technologies relating to genetic markers associated with adverse drug reactions caused by several popular pharmaceutical products. We have obtained ISO 13485 and GMP certifications, and are manufacturing our DNA genetic tests under the most stringent guidelines. We also have validated our DNA genetic tests with clinical studies that involved hundreds and thousands of patients. Today, our DNA genetic tests are available worldwide, receiving IVD clearance from the Ministry of Health and Welfare of Taiwan.